Valneva Reports Further Heterologous Booster Data for its … – BioSpace

Skip to main content Published: Dec 30, 2022 Saint-Herblain (France),December30,2022 – ValnevaSE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported further heterologous booster data from an exploratory, small clinical study for its inactivated COVID-19 vaccine, VLA2001.In study VLA2001-3071, a subset of participants (three out of nine groups) received VLA2001 following two or […]

Continue reading
1 105 106 107 108 109 245